Read more
This book helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.
List of contents
1. Acitretin. 2. Acne Antibiotics. 3. Alitretinoin 4. Antiandrogens. 5. Antibiotics Commonly Used for Skin Infections. 6. Antifungals. 7. Antimalarials. 8. Antivirals. 9. Apremilast. 10. Azathioprine. 11. Azole Antihelminths. 12. Bexarotene. 13. Ciclosporin. 14. Colchicine. 15. Corticosteroids. 16. Cyclophosphamide. 17. Dapsone. 18. Dimethyl Fumarate. 19. Interleukin 4/13 inhibitors. 20. Interleukin (IL)-12/23 and IL-23 Inhibitors. 21. Interleukin-17. antagonists. 22. Isotretinoin. 23. Ivermectin. 24. Intravenous Immunoglobulin. 25. Janus Kinase (JAK) Inhibitors. 26. Malignant Melanoma Drug Treatments. 27. Methotrexate. 28. Mycophenolate Mofetil. 29. Omalizumab. 30. Potassium Iodide. 31. Propranolol. 32. Psoralens. 33. Rituximab. 34. Sulfapyridine & Sulfamethoxy- pyridazine. 35. Thalidomide. 36. Tumour Necrosis Factor Antagonists. 37. Vismodegib. 38. Systemic Treatment in Children. 39. Kidney Disease. 40. Systemic Therapy & Liver Disease. 41. Systematic Therapy in Older People.
About the author
Edited by
Sarah H. Wakelin, BSc, MB, BS, FRCP, Consultant Dermatologist and Honorary Seniro Lecturer, Imperial College Healthcare NHS Trust, London, UK
Howard I. Maibach, MD, Professor of Dermatology, Department of Dermatology, University of California, San Francisco, USA
Clive B. Archer, BSc, MBBS, MSc Med Ed, MD, PhD (Lond), FRCP, Consultant Dermatologist, St John’s Institute of Dermatology, Guy’s and St. Thomas’ Hospitals NHS Foundation Trust, Honorary Professor of Dermatology and Immunopharmacology (UCLan) and Honorary Senior Lecturer (KCL), London, UK
Summary
This book helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.
